Cessatech investor relations material

Cessatech A/S is a biopharmaceutical company dedicated to identifying, developing and commercializing drugs for children with the potential to treat cancer and fibrotic disorders. The company's focus of research and development is based on the proteins in regulatory T-cells (Tregs) that suppress an immune system response to secondary disease processes, such as cancer and fibrosis.